Nustede R, Schmidt W E, Jäger M, Stöckmann F, Köhler H, Fölsch U R, Peiper H J
Department of Surgery, Georg-August-University, Göttingen, Germany.
Int J Pancreatol. 1994 Jun;15(3):209-14. doi: 10.1007/BF02924196.
The intraduodenal application of a potent protease inhibitor (camostate, 600 mg) causes a significant increase in basal pancreatic secretion in the manner of a negative-feedback mechanism. The integrated protein secretion during the entire study period was 9.9 +/- 1.8 g in 120 min. The iv application of anti-GRP immunoglobulin caused a significant reduction to 5.0 +/- g in 120 min. No significant changes in the plasma concentrations of GRP and CCK were detectable. The increased secretion occurring after the administration of the protease inhibitor could be mediated by neural GRP-dependent mechanisms. These may also be relevant for CCK-dependent factors, which are only briefly mentioned.
在十二指肠内应用一种强效蛋白酶抑制剂(抑肽酶,600毫克)会以负反馈机制的方式导致基础胰腺分泌显著增加。在整个研究期间,120分钟内的综合蛋白质分泌量为9.9±1.8克。静脉注射抗胃泌素释放肽免疫球蛋白导致120分钟内显著降至5.0±克。未检测到胃泌素释放肽和胆囊收缩素的血浆浓度有显著变化。蛋白酶抑制剂给药后出现的分泌增加可能由神经胃泌素释放肽依赖性机制介导。这些机制可能也与胆囊收缩素依赖性因素有关,对此仅作了简要提及。